Author Question: NPH refers to a/an ________. A) organ B) disease C) drug D) ... (Read 14 times)

ashley

  • Hero Member
  • *****
  • Posts: 584
NPH refers to a/an ________.
 
  A) organ
  B) disease
  C) drug
  D) hormone

Question 2

All of the following are TRUE about NSAIDs EXCEPT ________.
 
  A) they can decrease mild-to-moderate pain
  B) they are used to treat osteoarthritis and orthopedic injuries
  C) they are corticosteroids
  D) they can decrease mild-to-moderate inflammation



harveenkau8139

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

C
Explanation: A) NPH is a type of insulin drug, not an organ.
B) NPH is a type of insulin drug, not a disease.
C) Correct NPH is a type of insulin drug used to treat diabetes mellitus.
D) NPH is a type of insulin drug, not a hormone.

Answer to Question 2

C
Explanation: A) This is a true statement.
B) This is a true statement.
C) Correct Nonsteroidal anti-inflammatory drugs (NSAIDs) are not corticosteroids.
D) This is a true statement.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

More than nineteen million Americans carry the factor V gene that causes blood clots, pulmonary embolism, and heart disease.

Did you know?

Nearly 31 million adults in America have a total cholesterol level that is more than 240 mg per dL.

Did you know?

Long-term mental and physical effects from substance abuse include: paranoia, psychosis, immune deficiencies, and organ damage.

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library